MISSISSAUGA, Ontario, June 14, 2011 /PRNewswire/ -- Theramed Corporation (“Theramed”) announces that it will launch ebb™ and jetty™ at the 67th Clinical Meeting of the Society of Obstetricians and Gynecologists of Canada. The two newly developed medical devices are to be used to advance the practice of obstetrics, from Glenveigh International, LLC (“Glenveigh”). Both medical device products have been approved for sale by Health Canada, and Theramed will begin distributing these products on June 17th. “We are very excited to partner with Glenveigh Medical in advancing obstetrics for healthy moms and babies in Canada,” commented Bill Baugh, Theramed’s Chief Executive Officer.
About the ebb™ Complete Tamponade System
ebb™ is a complete tamponade solution for postpartum hemorrhage. Designed by world-renowned maternal-fetal medicine specialists Michael A. Belfort and Gary A. Dildy, the ebb™ balloon is made of a malleable yet extremely strong material, allowing ebb™ to expand and conform to any uterine shape. ebb™ also features a vaginal balloon to control vaginal bleeding and act as an anchor to support the uterine balloon. External ports allow independent control of inflation, deflation, irrigation, and drainage.
About the jetty™ Vaginal Repair Balloon
jetty™ is indicated for use during episiotomy and vaginal laceration repair to temporarily prevent the postpartum discharge of fluids from the vagina in order to assist with the repair procedure. jetty™ provides clarity and cleanliness for a timely, effective repair, and it eliminates the need for vaginal packing with gauze or sponges.
About Theramed Corporation
Theramed Corporation, headquartered in Mississauga, Ontario, is a specialty pharmaceutical company, focused on the development, acquisition, in-licensing, marketing, and distribution of medical products in Canada. The Company is dedicated to bringing new-to-market and well-established healthcare innovations to Canadian Physicians and Hospitals, be these Pharmaceuticals, Biotech products, or Medical Devices. The company currently markets Delatestryl®, Viroptic®, CollatampG® and FSME-IMMUN®.
About Glenveigh International, LLC
Glenveigh is a life science and medical technology company focused on advancing the practice of obstetrics, with aspirations to rapidly become the market leader in the OB/GYN field. Formed in 2004 by a maternal-fetal medicine (MFM) specialist, Glenveigh is founded on the core mission of improving the lives of pregnant mothers and their babies.
For more information on ebb™ or jetty™, marketing medical innovations in Canada, or on Theramed, please contact:
T.W. (Bill) Baugh III
President and CEO
e-mail: bbaugh@theramed.com
Tel: 905-564-5009 or 800-305-4441
http://www.theramed.com
SOURCE Theramed Corporation
